nodes	percent_of_prediction	percent_of_DWPC	metapath
Clemastine—CYP3A4—bone cancer	0.993	1	CbGaD
Clemastine—Eletriptan—CYP3A4—bone cancer	0.000306	0.397	CrCbGaD
Clemastine—Azelastine—CYP3A4—bone cancer	0.000265	0.344	CrCbGaD
Clemastine—Wheezing—Cisplatin—bone cancer	0.000203	0.0307	CcSEcCtD
Clemastine—Loperamide—CYP3A4—bone cancer	0.0002	0.259	CrCbGaD
Clemastine—Haemolytic anaemia—Cisplatin—bone cancer	0.000168	0.0254	CcSEcCtD
Clemastine—Nasal congestion—Cisplatin—bone cancer	0.000166	0.0252	CcSEcCtD
Clemastine—Irritability—Cisplatin—bone cancer	0.000145	0.0219	CcSEcCtD
Clemastine—Neuritis—Epirubicin—bone cancer	0.000143	0.0218	CcSEcCtD
Clemastine—Neuritis—Doxorubicin—bone cancer	0.000133	0.0201	CcSEcCtD
Clemastine—Sweating increased—Cisplatin—bone cancer	0.000127	0.0193	CcSEcCtD
Clemastine—Neuropathy peripheral—Cisplatin—bone cancer	0.000114	0.0174	CcSEcCtD
Clemastine—Tinnitus—Cisplatin—bone cancer	9.77e-05	0.0148	CcSEcCtD
Clemastine—Photosensitivity—Methotrexate—bone cancer	9.46e-05	0.0144	CcSEcCtD
Clemastine—Photosensitivity—Epirubicin—bone cancer	8.86e-05	0.0134	CcSEcCtD
Clemastine—Vision blurred—Cisplatin—bone cancer	8.59e-05	0.013	CcSEcCtD
Clemastine—Tremor—Cisplatin—bone cancer	8.54e-05	0.013	CcSEcCtD
Clemastine—Photosensitivity—Doxorubicin—bone cancer	8.19e-05	0.0124	CcSEcCtD
Clemastine—Irritability—Methotrexate—bone cancer	7.93e-05	0.012	CcSEcCtD
Clemastine—Convulsion—Cisplatin—bone cancer	7.9e-05	0.012	CcSEcCtD
Clemastine—Diplopia—Epirubicin—bone cancer	7.78e-05	0.0118	CcSEcCtD
Clemastine—Anaphylactic shock—Cisplatin—bone cancer	7.44e-05	0.0113	CcSEcCtD
Clemastine—Thrombocytopenia—Cisplatin—bone cancer	7.29e-05	0.0111	CcSEcCtD
Clemastine—Tachycardia—Cisplatin—bone cancer	7.26e-05	0.011	CcSEcCtD
Clemastine—Diplopia—Doxorubicin—bone cancer	7.19e-05	0.0109	CcSEcCtD
Clemastine—Hyperhidrosis—Cisplatin—bone cancer	7.19e-05	0.0109	CcSEcCtD
Clemastine—Anorexia—Cisplatin—bone cancer	7.09e-05	0.0108	CcSEcCtD
Clemastine—Hypotension—Cisplatin—bone cancer	6.95e-05	0.0106	CcSEcCtD
Clemastine—Paraesthesia—Cisplatin—bone cancer	6.68e-05	0.0101	CcSEcCtD
Clemastine—Photosensitivity reaction—Methotrexate—bone cancer	6.55e-05	0.00995	CcSEcCtD
Clemastine—Decreased appetite—Cisplatin—bone cancer	6.47e-05	0.00982	CcSEcCtD
Clemastine—Drowsiness—Methotrexate—bone cancer	6.4e-05	0.00972	CcSEcCtD
Clemastine—Pollakiuria—Epirubicin—bone cancer	6.21e-05	0.00942	CcSEcCtD
Clemastine—Photosensitivity reaction—Epirubicin—bone cancer	6.13e-05	0.00931	CcSEcCtD
Clemastine—Feeling abnormal—Cisplatin—bone cancer	6.13e-05	0.00931	CcSEcCtD
Clemastine—Drowsiness—Epirubicin—bone cancer	5.99e-05	0.00909	CcSEcCtD
Clemastine—Agranulocytosis—Methotrexate—bone cancer	5.98e-05	0.00907	CcSEcCtD
Clemastine—Neuropathy peripheral—Epirubicin—bone cancer	5.87e-05	0.00891	CcSEcCtD
Clemastine—Pollakiuria—Doxorubicin—bone cancer	5.74e-05	0.00872	CcSEcCtD
Clemastine—Photosensitivity reaction—Doxorubicin—bone cancer	5.68e-05	0.00861	CcSEcCtD
Clemastine—Agranulocytosis—Epirubicin—bone cancer	5.59e-05	0.00848	CcSEcCtD
Clemastine—Drowsiness—Doxorubicin—bone cancer	5.54e-05	0.00841	CcSEcCtD
Clemastine—Neuropathy peripheral—Doxorubicin—bone cancer	5.43e-05	0.00825	CcSEcCtD
Clemastine—Tinnitus—Methotrexate—bone cancer	5.36e-05	0.00813	CcSEcCtD
Clemastine—Asthenia—Cisplatin—bone cancer	5.34e-05	0.0081	CcSEcCtD
Clemastine—Agranulocytosis—Doxorubicin—bone cancer	5.17e-05	0.00785	CcSEcCtD
Clemastine—Chills—Methotrexate—bone cancer	5.16e-05	0.00783	CcSEcCtD
Clemastine—Diarrhoea—Cisplatin—bone cancer	5.09e-05	0.00773	CcSEcCtD
Clemastine—Tinnitus—Epirubicin—bone cancer	5.02e-05	0.00761	CcSEcCtD
Clemastine—Chills—Epirubicin—bone cancer	4.83e-05	0.00732	CcSEcCtD
Clemastine—Vomiting—Cisplatin—bone cancer	4.73e-05	0.00718	CcSEcCtD
Clemastine—Vision blurred—Methotrexate—bone cancer	4.72e-05	0.00716	CcSEcCtD
Clemastine—Tinnitus—Doxorubicin—bone cancer	4.64e-05	0.00704	CcSEcCtD
Clemastine—Tension—Epirubicin—bone cancer	4.59e-05	0.00697	CcSEcCtD
Clemastine—Nervousness—Epirubicin—bone cancer	4.55e-05	0.0069	CcSEcCtD
Clemastine—Vertigo—Methotrexate—bone cancer	4.5e-05	0.00682	CcSEcCtD
Clemastine—Chills—Doxorubicin—bone cancer	4.47e-05	0.00678	CcSEcCtD
Clemastine—Nausea—Cisplatin—bone cancer	4.42e-05	0.00671	CcSEcCtD
Clemastine—Vision blurred—Epirubicin—bone cancer	4.41e-05	0.0067	CcSEcCtD
Clemastine—Convulsion—Methotrexate—bone cancer	4.34e-05	0.00658	CcSEcCtD
Clemastine—Agitation—Epirubicin—bone cancer	4.3e-05	0.00653	CcSEcCtD
Clemastine—Tension—Doxorubicin—bone cancer	4.25e-05	0.00645	CcSEcCtD
Clemastine—Nervousness—Doxorubicin—bone cancer	4.21e-05	0.00639	CcSEcCtD
Clemastine—Vertigo—Epirubicin—bone cancer	4.21e-05	0.00638	CcSEcCtD
Clemastine—Palpitations—Epirubicin—bone cancer	4.14e-05	0.00628	CcSEcCtD
Clemastine—Confusional state—Methotrexate—bone cancer	4.12e-05	0.00625	CcSEcCtD
Clemastine—Anaphylactic shock—Methotrexate—bone cancer	4.08e-05	0.0062	CcSEcCtD
Clemastine—Vision blurred—Doxorubicin—bone cancer	4.08e-05	0.0062	CcSEcCtD
Clemastine—Convulsion—Epirubicin—bone cancer	4.06e-05	0.00616	CcSEcCtD
Clemastine—Thrombocytopenia—Methotrexate—bone cancer	4e-05	0.00607	CcSEcCtD
Clemastine—Agitation—Doxorubicin—bone cancer	3.98e-05	0.00604	CcSEcCtD
Clemastine—Hyperhidrosis—Methotrexate—bone cancer	3.95e-05	0.00599	CcSEcCtD
Clemastine—Vertigo—Doxorubicin—bone cancer	3.89e-05	0.00591	CcSEcCtD
Clemastine—Anorexia—Methotrexate—bone cancer	3.89e-05	0.00591	CcSEcCtD
Clemastine—Confusional state—Epirubicin—bone cancer	3.85e-05	0.00585	CcSEcCtD
Clemastine—Palpitations—Doxorubicin—bone cancer	3.83e-05	0.00581	CcSEcCtD
Clemastine—Anaphylactic shock—Epirubicin—bone cancer	3.82e-05	0.0058	CcSEcCtD
Clemastine—Hypotension—Methotrexate—bone cancer	3.82e-05	0.00579	CcSEcCtD
Clemastine—Convulsion—Doxorubicin—bone cancer	3.75e-05	0.0057	CcSEcCtD
Clemastine—Thrombocytopenia—Epirubicin—bone cancer	3.74e-05	0.00568	CcSEcCtD
Clemastine—Tachycardia—Epirubicin—bone cancer	3.73e-05	0.00566	CcSEcCtD
Clemastine—Hyperhidrosis—Epirubicin—bone cancer	3.69e-05	0.00561	CcSEcCtD
Clemastine—Insomnia—Methotrexate—bone cancer	3.69e-05	0.0056	CcSEcCtD
Clemastine—Paraesthesia—Methotrexate—bone cancer	3.67e-05	0.00556	CcSEcCtD
Clemastine—Anorexia—Epirubicin—bone cancer	3.64e-05	0.00553	CcSEcCtD
Clemastine—Somnolence—Methotrexate—bone cancer	3.63e-05	0.00551	CcSEcCtD
Clemastine—Dyspepsia—Methotrexate—bone cancer	3.59e-05	0.00545	CcSEcCtD
Clemastine—Hypotension—Epirubicin—bone cancer	3.57e-05	0.00542	CcSEcCtD
Clemastine—Confusional state—Doxorubicin—bone cancer	3.57e-05	0.00541	CcSEcCtD
Clemastine—Decreased appetite—Methotrexate—bone cancer	3.55e-05	0.00539	CcSEcCtD
Clemastine—Anaphylactic shock—Doxorubicin—bone cancer	3.54e-05	0.00537	CcSEcCtD
Clemastine—Fatigue—Methotrexate—bone cancer	3.52e-05	0.00534	CcSEcCtD
Clemastine—Thrombocytopenia—Doxorubicin—bone cancer	3.46e-05	0.00525	CcSEcCtD
Clemastine—Insomnia—Epirubicin—bone cancer	3.46e-05	0.00524	CcSEcCtD
Clemastine—Tachycardia—Doxorubicin—bone cancer	3.45e-05	0.00524	CcSEcCtD
Clemastine—Paraesthesia—Epirubicin—bone cancer	3.43e-05	0.00521	CcSEcCtD
Clemastine—Hyperhidrosis—Doxorubicin—bone cancer	3.42e-05	0.00519	CcSEcCtD
Clemastine—Somnolence—Epirubicin—bone cancer	3.4e-05	0.00516	CcSEcCtD
Clemastine—Anorexia—Doxorubicin—bone cancer	3.37e-05	0.00511	CcSEcCtD
Clemastine—Feeling abnormal—Methotrexate—bone cancer	3.37e-05	0.00511	CcSEcCtD
Clemastine—Dyspepsia—Epirubicin—bone cancer	3.36e-05	0.0051	CcSEcCtD
Clemastine—Decreased appetite—Epirubicin—bone cancer	3.32e-05	0.00504	CcSEcCtD
Clemastine—Hypotension—Doxorubicin—bone cancer	3.3e-05	0.00501	CcSEcCtD
Clemastine—Fatigue—Epirubicin—bone cancer	3.29e-05	0.005	CcSEcCtD
Clemastine—Constipation—Epirubicin—bone cancer	3.27e-05	0.00496	CcSEcCtD
Clemastine—Insomnia—Doxorubicin—bone cancer	3.2e-05	0.00485	CcSEcCtD
Clemastine—Paraesthesia—Doxorubicin—bone cancer	3.18e-05	0.00482	CcSEcCtD
Clemastine—Feeling abnormal—Epirubicin—bone cancer	3.15e-05	0.00478	CcSEcCtD
Clemastine—Somnolence—Doxorubicin—bone cancer	3.14e-05	0.00477	CcSEcCtD
Clemastine—Dyspepsia—Doxorubicin—bone cancer	3.11e-05	0.00472	CcSEcCtD
Clemastine—Decreased appetite—Doxorubicin—bone cancer	3.07e-05	0.00466	CcSEcCtD
Clemastine—Fatigue—Doxorubicin—bone cancer	3.05e-05	0.00463	CcSEcCtD
Clemastine—Constipation—Doxorubicin—bone cancer	3.02e-05	0.00459	CcSEcCtD
Clemastine—Asthenia—Methotrexate—bone cancer	2.93e-05	0.00445	CcSEcCtD
Clemastine—Feeling abnormal—Doxorubicin—bone cancer	2.91e-05	0.00442	CcSEcCtD
Clemastine—Diarrhoea—Methotrexate—bone cancer	2.79e-05	0.00424	CcSEcCtD
Clemastine—Asthenia—Epirubicin—bone cancer	2.74e-05	0.00416	CcSEcCtD
Clemastine—Dizziness—Methotrexate—bone cancer	2.7e-05	0.0041	CcSEcCtD
Clemastine—Diarrhoea—Epirubicin—bone cancer	2.61e-05	0.00397	CcSEcCtD
Clemastine—Vomiting—Methotrexate—bone cancer	2.6e-05	0.00394	CcSEcCtD
Clemastine—Headache—Methotrexate—bone cancer	2.56e-05	0.00388	CcSEcCtD
Clemastine—Asthenia—Doxorubicin—bone cancer	2.54e-05	0.00385	CcSEcCtD
Clemastine—Dizziness—Epirubicin—bone cancer	2.53e-05	0.00383	CcSEcCtD
Clemastine—Vomiting—Epirubicin—bone cancer	2.43e-05	0.00369	CcSEcCtD
Clemastine—Nausea—Methotrexate—bone cancer	2.43e-05	0.00368	CcSEcCtD
Clemastine—Diarrhoea—Doxorubicin—bone cancer	2.42e-05	0.00367	CcSEcCtD
Clemastine—Headache—Epirubicin—bone cancer	2.39e-05	0.00363	CcSEcCtD
Clemastine—Dizziness—Doxorubicin—bone cancer	2.34e-05	0.00355	CcSEcCtD
Clemastine—Nausea—Epirubicin—bone cancer	2.27e-05	0.00344	CcSEcCtD
Clemastine—Vomiting—Doxorubicin—bone cancer	2.25e-05	0.00341	CcSEcCtD
Clemastine—Headache—Doxorubicin—bone cancer	2.22e-05	0.00336	CcSEcCtD
Clemastine—Nausea—Doxorubicin—bone cancer	2.1e-05	0.00319	CcSEcCtD
